Stephens & Co. Upgrades CareDx to Overweight, Announces $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Mason Carrico has upgraded CareDx (NASDAQ:CDNA) from Equal-Weight to Overweight and set a price target of $10.
November 09, 2023 | 2:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx has been upgraded to Overweight by Stephens & Co. with a price target of $10.
The upgrade from Equal-Weight to Overweight by Stephens & Co. indicates a positive outlook for CareDx. The price target of $10 also suggests potential upside for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100